News - Marketing authorisation medicines for human use

1. Request to take over the Fucidin marketing authorisation

   The company Leo Pharma B.V. has informed the Medicines Evaluation Board (MEB) that the production of the antibiotic Fucidin ...

   News item | 31-03-2020 | 17:00

2. Request to take over the pyridoxine hydrochloride marketing authorisation

   The company Pharmachemie B.V. has requested the Medicines Evaluation Board (MEB) to withdraw marketing authorisation for ...

   News item | 30-03-2020 | 17:00

3. Changes to product information policy

   The Medicines Evaluation Board (MEB) recently revised a number of policy documents for pharmaceutical companies relating to the ...

   News item | 23-03-2020 | 12:00

4. Amended policy on DHPCs

   The Medicines Evaluation Board (MEB) has amended its policy on Direct Healthcare Professional Communications (DHPCs). This ...

   News item | 21-02-2020 | 12:00

5. MEB confirms current legal status of supply ibuprofen 200 mg

   The Medicines Evaluation Board (MEB) has evaluated whether the recent European review of the adverse events on heart and blood ...

   News item | 03-08-2015 | 00:00